Emcure to expand use of Poviztra for MASH indication after CDSCO nod
Poviztra® is manufactured and imported from Novo Nordisk's European manufacturing facility and contains innovator rDNA-origin…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
obesity
Ajanta Pharma outlines five trends shaping future of obesity care in India
India is approaching a pivotal moment in the evolution of obesity and metabolic health management. As awareness grows among…
Rona Therapeutics announces IND filing of RN3161 for obesity
Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, announced the successful submission of RN3161…
China’s obesity market forecasts rise with homegrown therapies and late-stage pipeline
With ten other drugs in Phase III development by domestic companies, according to GlobalData’s Pharmaceutical Intelligence Center,…
Lilly partners with API to launch a CME for obesity
The Obesity Gurukul program will aim to offer a structured and immersive learning experience for over 20,000 healthcare…
Rice University’s ROGUE device implants a ‘living pharmacy’ to combat diabetes and obesity
The ROGUE device is significant for countries like India as it offers a ‘living pharmacy’ that produces and adjusts diabetes…
Pfizer advances development of once-daily danuglipron
The company plans to conduct dose optimization studies with a focus on the preferred formulation to inform the registration…
GLP-1R agonists’ type 2 diabetes and obesity market to reach $125 billion in 7MM by 2033: GlobalData
According to GlobalData, more than 190 million people currently live with type 2 diabetes and/or obesity in 7MM, and the numbers…
Obesity care needs greater revolution: GlobalData
According to the KOLs interviewed by GlobalData, the diagnostic and management tools for obesity need to be updated and patients…
GLP-1R agonist withdrawal effect on weight loss and cardiovascular risks remains unmet need:…
Zepbound is Eli Lilly’s new glucagon-like peptide-1/gastric inhibitory polypeptide (GLP-1/GIP) dual agonist, approved by the FDA…